Xenia, United States
Nexture Bio, founded in 2023 and headquartered in the United States, focuses on creating animal-component-free adherent cell culture products across various applications. Their innovations cater to the Biotechnology and Food and Beverage industries, offering biodegradable, plant-based alternatives to traditional animal-based and synthetic cell culture solutions.
Central to their offerings are microcarriers, scaffolds, and cell-attachment factors, alongside a suite of scientific services. These products aim to support scalable adherent cell culture in life sciences, food, and personal care sectors.
The company recently secured an investment from Big Idea Ventures on 01 December 2023. This backing reflects confidence in Nexture Bio's potential to disrupt traditional cell culture methodologies with sustainable and safe solutions, making it an attractive proposition for investors seeking innovation in biotechnology and food tech arenas.
